Results 221 to 230 of about 1,663,252 (327)

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Intradialytic kinetics of cardiac biomarkers during high-flux haemodialysis and postdilution haemodiafiltration: study protocol for a randomised crossover trial. [PDF]

BMJ Open
Drivsholm CL, Nygaard L, Glerup RI, Birnum ATS, Jensen JD, Svensson M.   +5 more
europepmc   +1 more source

Data Sheet 1_Predictive value of HBeAg titer dynamics for HBsAg clearance in pediatric chronic hepatitis B.pdf

Sukjin Hong (20991200), Jun Hyun Hwang (3190296), Keumoung Kim (20991203), Younghae Do (20991206), Naeun Kwak (20991209), Hyo Rim Suh (20991212), Sujin Choi (3190689), Ben Kang (2266984), Byung-Ho Choe (9364418)   +8 more
openalex   +1 more source

Comparison of glomerular filtration rate estimates vs. 24‐h creatinine clearance in HIV‐positive patients [PDF]

, 2009
Giovanni Ravasi, Marinella Lauriola, Carmine Tinelli, Marion Brandolini, Alessia Uglietti, Renato Maserati   +5 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Efficacy of 4% 5-Fluorouracil Cream in the Treatment of Actinic Keratoses: A Single-Center Experience. [PDF]

J Clin Med
Cantisani C, Di Guardo A, Paolino G, Balázs N, Boostani M, Kiss N, Conforti C, Feresin F, Carugno A, Gargano L, Losco L, Nisticò SP, Pellacani G.   +12 more
europepmc   +1 more source

Enhanced bacterial clearance in HRB-Mertk^-/- is not altered by neutralization of IFNγ.

Matthew K. McPeek (21101173), Jessica R. Martin (6411641), John C. Gomez (6411644), Yitong Li (2690047), Hong Dang (2090011), H. Shelton Earp (251553), Claire M. Doerschuk (2993703)   +6 more
openalex   +1 more source

Processing and clearance of atrial natriuretic factor [PDF]

, 1991
Gerbes, Alexander L., Henriksen, Jens H., Vollmar, Angelika M.   +2 more
core   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Dynamics of anal HPV infection after 9vHPV vaccination in men who have sex with men (MSM) with HIV: A prospective, controlled cohort study. [PDF]

Hum Vaccin Immunother
Lin KY, Lai SL, Huang YS, Sun HY, Chuang YC, Jan IS, Liu WC, Fang CT, Hung CC.   +8 more
europepmc   +1 more source